Surveillance and prevention of endometrial cancer in BRCA1 mutation carriers are not advised by the Belgian Society of Human Genetics, because the cumulative risk of serous endometrial cancer is less than 5% at 70 years of age. Here, BRCA1 is linked to endometrial cancer.